Skip to Main content Skip to Navigation
Journal articles

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

Annabelle Bédard X. Basagaña Josep María Anto Judith Garcia-Aymerich Philippe Devillier 1 Sylvie Arnavielhe 2 Anna Bedbrook 3 Gabrielle L. Onorato 4 Wienczyslawa Czarlewski Ruth Brigid Murray Rute Almeida João Almeida Fonseca J. Correia da Sousa Elísio Costa Mário A. Morais-Almeida A. Todo-Bom Lorenzo Cecchi Giulia de Feo Maddalena Illario Enrica Menditto Riccardo Monti Cristiana Stellato M. T. Ventura 5 Isabella Annesi-Maesano 5 Isabelle Bosse 6 Jean François M. Fontaine 7 Nhân Pham-Thi 8 Michel Thibaudon 9 Peter D. Schmid-Grendelmeier François Spertini N. Chavannes Wytske Johanna Fokkens Sietze Reitsma Ruta Dubakiene Regina Emuzyte Violeta Kvedariene Arũnas Valiulis P. Kuna Bolesław Samolinski Ludger Klimek Ralph Mösges Oliver Pfaar Sara Shamai Regina Elisabeth Roller-Wirnsberger Peter Valentin Tomazic Dermot P. Ryan Aziz Sheikh Tari M.K. Haahtela Sanna Katriina Toppila-Salmi Erkka Juhani Valovirta Victoria Cardona Joaquim Mullol Antonio Luís Valero Michaël P. Makris N. G. Papadopoulos Emmanuel P. Prokopakis Fotis Psarros Claus Bachert Peter William Hellings Benoit Pugin Carsten Bindslev-Jensen Esben E. Eller Inger Kull Erik Melén Magnus C. Wickman Govert de Vries Michiel van Eerd Ioana O. Agache Ignacio Javier Ansotegui Sinthia Z. Bosnic-Anticevich Álvaro Augusto Cruz Thomas B. Casale J. C. Ivancevich Désirée E.S. Larenas-Linnemann Mikhail Sofiev Dana V. Wallace Susan Waserman Arzu Yorgancioglu Daniel Laune 2 Jean J. Bousquet 3, 10, *
Abstract : Background: The analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in 17 European countries during and outside the estimated pollen season. The aim was to collect novel information including the phenotypic characteristics of the users. Methods: The Allergy Diary–MASK-air–mobile phone app, freely available via Google Play and App, was used to collect the data of daily visual analogue scales (VASs) for overall allergic symptoms and medication use. Fluticasone Furoate (FF), Mometasone Furoate (MF), Azelastine Fluticasone Proprionate combination (MPAzeFlu) and eight oral H1-antihistamines were studied. Phenotypic characteristics were recorded at entry. The ARIA severity score was derived from entry data. This was an a priori planned analysis. Results: 9037 users filled in 70,286 days of VAS in 2016, 2017 and 2018. The ARIA severity score was lower outside than during the pollen season. Severity was similar for all treatment groups during the pollen season, and lower in the MPAzeFlu group outside the pollen season. Days with MPAzeFlu had lower VAS levels and a higher frequency of monotherapy than the other treatments during the season. Outside the season, days with MPAzeFlu also had a higher frequency of monotherapy. The number of reported days was significantly higher with MPAzeFlu during and outside the season than with MF, FF or oral H1-antihistamines. Conclusions: This study shows that the overall efficacy of treatments is similar during and outside the pollen season and indicates that medications are similarly effective during the year.
Document type :
Journal articles
Complete list of metadata
Contributor : Équipe Hal Uvsq <>
Submitted on : Wednesday, June 2, 2021 - 2:14:39 PM
Last modification on : Thursday, June 3, 2021 - 10:21:34 AM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License



Annabelle Bédard, X. Basagaña, Josep María Anto, Judith Garcia-Aymerich, Philippe Devillier, et al.. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study. Clinical and Translational Allergy, BioMed Central, 2020, 10 (1), ⟨10.1186/s13601-020-00342-x⟩. ⟨hal-03109218⟩



Record views


Files downloads